Found: 7
Select item for more details and to access through your institution.
Immunogenicity and Protective Potential of Mucosal Vaccine Formulations Based on Conserved Epitopes of Influenza A Viruses Fused to an Innovative Ring Nanoplatform in Mice and Chickens.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.772550
- By:
- Publication type:
- Article
Editorial: Innovative Therapeutic and Vaccine Approaches Against Respiratory Pathogens.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01605
- By:
- Publication type:
- Article
M2e nanovaccines supplemented with recombinant hemagglutinin protect chickens against heterologous HPAI H5N1 challenge.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00944-7
- By:
- Publication type:
- Article
Evaluation of the Immunomodulatory Properties of Streptococcus suis and Group B Streptococcus Capsular Polysaccharides on the Humoral Response.
- Published in:
- Pathogens, 2017, v. 6, n. 2, p. 16, doi. 10.3390/pathogens6020016
- By:
- Publication type:
- Article
Initial steps of the pathogenesis of the infection caused by Streptococcus suis: fighting against nonspecific defenses.
- Published in:
- FEBS Letters, 2016, v. 590, n. 21, p. 3772, doi. 10.1002/1873-3468.12364
- By:
- Publication type:
- Article
Structure determination of Streptococcus suis serotype 14 capsular polysaccharide.
- Published in:
- Biochemistry & Cell Biology, 2013, v. 91, n. 2, p. 49, doi. 10.1139/bcb-2012-0036
- By:
- Publication type:
- Article